Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from JBM (Healthcare) Ltd. ( (HK:2161) ) is now available.
JBM (Healthcare) Limited has completed the acquisition of a target company, gaining a 90% interest and making it a non-wholly owned subsidiary. This acquisition, valued at HK$171 million, is expected to enhance JBM’s portfolio by integrating the target company’s well-known product, Tin Hee Tong Tin Hee Pills, into its offerings. The move is anticipated to create synergies and expand JBM’s market reach, leveraging its experience in brand management and distribution networks.
More about JBM (Healthcare) Ltd.
JBM (Healthcare) Limited operates in the healthcare industry, focusing on proprietary Chinese medicines and health and wellness products. The company is known for its expertise in promoting branded medicines and has a strong market presence in Hong Kong and mainland China.
YTD Price Performance: -6.32%
Average Trading Volume: 856,775
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.5B
For an in-depth examination of 2161 stock, go to TipRanks’ Stock Analysis page.